Analytical Data
-
Gene name
a2ML1
- Application
-
Alternative Names
CPAMD9; C3 And PZP-Like,Alpha-2-Macroglobulin Domain Containing 9
-
Species
Human
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
A8K2U0
-
Expression Region
Gln1119~Thr1348
-
Molecular Weight
29kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The research on A2ML1 recombinant protein is rooted in its significant potential implications for human health, particularly in the context of various genetic disorders. A2ML1, or Alpha-2-Macroglobulin-Like 1, is a protein that belongs to the alpha-macroglobulin family and plays a crucial role in regulating proteolytic activity in the extracellular space. It has been associated with genetic conditions, including syndromic and non-syndromic forms of intellectual disability and autism spectrum disorders, making it a protein of interest for genetic and biochemical studies. Additionally, recent advances in molecular biology techniques have enabled researchers to produce recombinant A2ML1, allowing for detailed functional analyses and investigation of its potential role in cellular processes. By studying the mechanisms through which A2ML1 may influence cell signaling, protease regulation, and neurodevelopment, scientists aim to uncover its contributions to disease pathology and explore therapeutic avenues. Understanding A2ML1 not only enhances our comprehension of its biological functions but also opens doors for novel strategies in diagnostics and treatment of related disorders, making it a significant area of contemporary biomedical research.
